|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/genetic-therapy-approaches/
课程评论:没有评论
本课程“基因治疗方法”将深入探讨基因治疗的最新技术和策略,旨在应对罕见病治疗的挑战。 **课程核心内容:** * **基因治疗技术概览:** 学习基因增强治疗、CRISPR基因编辑、自杀基因疗法、人类人工染色体以及反义寡核苷酸(ASO)等多种基因治疗手段。 * **已批准的基因疗法案例分析:** 详细研究Luxturna(治疗视网膜色素变性)、Zolgensma和Spinraza(治疗脊髓性肌萎缩症,SMA)等当前已获批准的基因疗法,并探讨其他相关治疗方法。 * **基因治疗设计与应用:** 讨论基因靶向与基因设计,以及基因治疗在疾病治疗中的具体应用。 * **基因治疗的挑战与注意事项:** 剖析基因治疗过程中遇到的困难,并为即将开展的基因治疗项目提供关键的指导和建议。 **课程背景与意义:** 全球有超过6500万人遭受基因疾病的困扰,其中大部分罕见病(约占已诊断的七千种罕见病的不到5%)目前仍被认为无法治愈。基因治疗的出现,为这些由遗传缺陷导致生活质量下降甚至缩短寿命的患者带来了“一次性治愈”的希望。 课程强调,基因治疗通过将健康的基因或功能性基因片段导入患者的靶细胞,以替代或修复病变基因,从而恢复细胞的正常功能。随着人类基因组计划的完成,对疾病遗传基础的认识不断加深,基因治疗方法的发展也日趋迅速。它被视为一种能够通过一次性干预实现长期疗效,相对于传统药物治疗具有显著优势的治疗手段,因此成为医药和生物技术领域研究的焦点。 本课程旨在培养合格的基因治疗专家,并推动高附加值基因治疗产品的开发,以期为罕见病患者早日带来“一次性治愈”的福音。
With this course, you will learn about the current gene therapy technologies and the approaches you can use for the rare disease you are targeting. Gene augmentation therapy, CRISPR gene editing, suicide gene (suicide gene), human artificial chromosome, and anti-sense oligonucleotide (ASO) based approaches will be discussed among genetic treatment approaches. At the same time, approaches used within the scope of currently approved genetic therapies, Luxturna (Retinitis Pigmentosa), Zolgensma and Spinraza (SMA), and other treatments will be examined in detail. Finally, we will discuss the difficulties encountered in genetic therapy approaches and what you should pay attention to before your genetic therapy projects.i.Gene Therapy: Introduction and Methodsii. Gene Therapy Strategiesiii. Gene Therapy Methodsiv. Gene Targeting and Genetic Designv. Gene Therapy in the Treatment of Diseasesvi. Challenges in Gene TherapyRadiChal's vision,"considered incurable">65 million people in the world with a genetic diseaseone-time recoveryTo provide a «one-shot cure»starting with the training of qualified specialists; to develop value-added products.Although there are approximately seven thousand rare diseases diagnosed; only less than 5% of these are thought to be curable. For this reason, it is indisputable how high the need for gene therapy methods is for individuals with rare diseases caused by genetic disorders that reduce their quality of life and shorten their lifespan. gene therapy; is accepted as a technique that changes a part of a person's genetics to repair a defective gene in the genome of a person suffering from hereditary/familial rare diseases or to maintain their functional characteristics. With the revelation of the healthy human genome code at the beginning of the 2000s, the genetic disorders underlying many diseases came to light and the development of gene therapy methods to repair these damaged DNA sequences gained momentum. The gene therapy method, which can be defined as 'transferring synthetic gene copies that will replace mutated genes and fulfill their natural function to the target cells of the patient with viral or non-viral transfer methods', is essential in achieving single-shot therapy compared to drugs or alternative medicine treatments. arguably has an advantage. For this reason, pharmaceutical and biotechnology companies have focused their treatment research in recent years, especially on gene therapy.